Intelligence · Patents
Patents expiring in 2041
Annual patent cliff calendar for 2041 — US pharmaceutical patents by expiration date.
- Patents
- 2,000
Quick answer
2,000 indexed pharmaceutical patents have expiration dates in 2041. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 11117972
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 11116838
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
granted -
US 11116830
Bacterial polysaccharide-conjugated carrier proteins and use thereof
granted -
US 11116823
Treatment of α-galactosidase a deficiency
granted -
US 11116797
Universal donor cells
granted -
US 11116740
Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
granted -
US 11116733
Topical dapsone and dapsone/adaplene compositions and methods for use thereof
granted -
US 11116717
Soluble estradiol capsule for vaginal insertion
granted -
US 11116214
Lice control composition and method
granted -
US 11116798
Universal donor cells
granted -
US 11116825
Cancer vaccine compositions and methods of using the same
granted -
US 11117865
Inhibitors of bromodomain-containing protein 4 (BRD4)
granted -
US 11117945
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 11117867
Crystalline salts of a plasma kallikrein inhibitor
granted -
US 11117934
Oncolytic virus platform to treat cancers with myxoma virus
granted -
US 11116839
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
granted -
US 11116843
Conjugated antisense compounds and their use
granted -
US 11117904
Compositions and methods for the delivery of therapeutics
granted -
US 11117900
Compounds useful as inhibitors of ATR kinase
granted -
CA 3174918
OPICAPONE MICRONISEE
granted -
WO 2021182981
OPICAPONE MICRONISÉE
granted -
US 11123286
Auris formulations for treating otic diseases and conditions
granted -
US 11125741
Compositions and methods for the detection of zinc
granted -
US 11123441
Methods and compositions for drug delivery
granted -
US 11124835
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted -
US 11124545
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
granted -
US 11124541
Chimeric melanocortin ligands and methods of use thereof
granted -
US 11124537
Inhibitors of glucocorticoid receptor
granted -
US 11124489
EPAC antagonists
granted -
US 11123371
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11123312
Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
granted -
US 11123285
Auris formulations for treating OTIC diseases and conditions
granted -
US 11122832
Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise
granted -
US 11123283
Soluble estradiol capsule for vaginal insertion
granted -
US 11123311
Methods of treating mental disorders
granted -
US 11123295
Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
granted -
US 11124839
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11123302
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
granted -
US 11123344
Bupropion as a modulator of drug activity
granted -
US 11123340
Small-molecule UT-A-selective urea transport inhibitors
granted -
US 11123357
Methods and compositions for treating oral mucositis
granted -
US 11123360
Oligonucleotides to treat eye disease
granted -
US 11123334
Compositions and methods for treating opioid overdose and opioid abuse
granted -
US 11123351
Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime
granted -
US 11123399
Modulators of complement activity
granted -
US 11123443
Htt repressors and uses thereof
granted -
US 11123431
Pharmaceutical compositions comprising meloxicam
granted -
US 11123377
Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
granted
Frequently asked questions
How many pharma patents expire in 2041?
2,000 published patents in our USPTO index have expiration dates falling in calendar year 2041.